Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05056597 · ClinicalTrials.gov registry record

Incentive Processing and Learning in Anorexia Nervosa and Bulimia Nervosa

A clinical trial of Anorexia Nervosa and Bulimia Nervosa, sponsored by University of California, San Diego.

Recruiting
Registry status
252
Enrollment target
1
Study location

NCT05056597: Recruiting study of Anorexia Nervosa and Bulimia Nervosa, sponsored by University of California, San Diego.

NCT05056597 is a study of Anorexia Nervosa and Bulimia Nervosa that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 252 participants, below the 944-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05056597, a study of Anorexia Nervosa and Bulimia Nervosa, is actively recruiting participants, sponsored by University of California, San Diego.

RECRUITING
Registry status
252 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate areas of the brain responsible for 'liking', 'wanting', and learning in adults with eating disorders using brain imaging techniques, computer tasks, a test meal, and self-report questionnaires and interviews. The investigators will study changes in brain activity using a procedure called functional magnetic resonance imaging (fMRI). This study will include 252 women with an eating disorder (63 AN-restricting type (AN-R), 63 AN-binge eating/purging type (AN-BP), 63 bulimia nervosa (BN)) and 63 healthy controls (HC) aged 18-39. Aim 1: To examine neural differences in 'liking' and 'wanting' in ED relative to HC. Aim 2: To examine differences in instrumental learning for reward and punishment in ED relative to HC. Aim 3: To examine how 'liking' and 'wanting' drive instrumental learning in ED and predict clinical symptoms at baseline and 1 year later. Exploratory Aim: To explore the associations of dopamine function, as measured by neuromelanin MRI (NM-MRI), with ED diagnosis and brain response to 'liking', 'wanting', and learning.

Primary Outcome

Brain activity associated with 'liking', 'wanting', and learning

Study Locations (1)

California

  • UCSD Eating Disorders Treatment and Research Program - La Jolla

Trial Details

FieldValue
Enrollment Target 252 participants
Start Date 2022-05-26
Est. Completion 2027-01
University of California, San Diego

775 total trials

What NCT05056597 shows while recruiting

NCT05056597 is an observational study that tracks outcomes without assigning an intervention. The registered 252 participants enrollment target is mid-sized for trials with a published cap, below the 944-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (73% lower).

The record links to 2 conditions, with Anorexia Nervosa appearing as the primary indexed condition, and to 0 interventions.

NCT05056597 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05056597 about?

NCT05056597 is a clinical study titled "Incentive Processing and Learning in Anorexia Nervosa and Bulimia Nervosa". The purpose of this study is to investigate areas of the brain responsible for 'liking', 'wanting', and learning in adults with eating disorders using brain imaging techniques, computer tasks, a test meal, and self-report questionnaires and interviews. The investigators will study changes in brain a...

What is the current status of trial NCT05056597?

This trial is currently recruiting. The enrollment target is 252 participants. The study started on 2022-05-26. Estimated completion is 2027-01.

What conditions does trial NCT05056597 study?

This clinical trial studies the following conditions: Anorexia Nervosa, Bulimia Nervosa.

Who is sponsoring clinical trial NCT05056597?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05056597 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anorexia Nervosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05056597's enrollment target sits among peer trials

252 4th of 43 higher than 40 of 43 other Anorexia Nervosa trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anorexia Nervosa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02314988 · 252 participants · Phase 2

    Tranexamic Acid to Reduce Blood Loss in Spine Surgery

  • NCT03941756 · 252 participants · NA

    Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma

  • NCT05219617 · 252 participants · Phase 3

    Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

  • NCT05384158 · 252 participants · NA

    Valuation in Depressed Mood, Anhedonia, and Anxiety

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05056597, the US trial registry maintained by the National Library of Medicine. NCT05056597 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.